IMPORTANT SAFETY INFORMATION:
NexGard® COMBO (esafoxolaner, eprinomectin, and
praziquantel topical solution) is for topical use only in cats. Use with caution
in cats with a history of seizures or neurologic disorders. The most frequently
reported adverse reactions include vomiting, application site reactions, and
anorexia. If ingested, hypersalivation may occur. Avoid direct contact with
application site until visibly dry. For more information, contact your
veterinarian, visit NexGardForPets.com or refer to the full prescribing
information.
NexGard® is a registered trademark and NexGard
COMBO™ is a trademark of Boehringer Ingelheim Animal Health
France, used under license. ©2025 Boehringer Ingelheim Animal Health USA
Inc., Duluth, GA. All rights reserved. HEARTGARD® and the Dog
& Hand logo® are registered trademark of Boehringer Ingelheim
Animal Health USA Inc. ©2025 Boehringer Ingelheim Animal Health USA Inc.,
Duluth, GA. All rights reserved.